Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 10, 1998, Pages 2003-2012

  Nozaki, Naoki ^a   Yamaguchi, Seiji ^a   Yamaoka, Minako ^a   Okuyama, Masaki ^a   Nakamura, Hidenori ^a   Tomoike, Hitonobu ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Heart failure; Matrix metalloproteinase; mRNA; Shedding; TNF receptor

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL SURFACE; CIRCULATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032190915     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0761     Document Type: Article

References (45)

1. ADERKA D, ENGELMANN H, HORNIK V, SKORNICK Y, WALLACE D, KUSHTAI G, 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51: 5602-5607.
2. BAZIL V, 1995. Physiologic enzymatic cleavage of leukocyte membrane molecules. Immunol Today 16: 135-140.
3. BRADLEY JR, THIRU S, POBER JS, 1995. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 146: 27-32.
4. CADRANEL J, PHILIPPE C, PHILIPPE B, MILLERSON B, FOUQUERAY B, MAYAUD C, BAUD L, 1993. Increased expression and occupancy of receptors for tumor necrosis factor on blood monocytes from tuberculosis patients. Clin Exp Immunol 94: 1042-1052.
5. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ, RUTTER WJ, 1979. Isolation of biologically active ribonucleic acid from enriched ribonuclease. Biochemistry 18: 5294-5299.
6. DUTKA DP, ELBORN JS, DELAMERE F, SHALE DJ, MORRIS GK, 1993. Tumour necrosis factor in a severe congestive cardiac failure. Br Heart J 70: 141-143.
7. FEINBERG AP, VOGLESTEIN B, 1983. A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13.
8. FERRARI R, BACHETTI T, CONFORTINI R, OPASICH C, FEBO O, CORTI A, CASSANI G, VISIOLI O, 1995. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479-1486.
9. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
10. FORT P, MARTY L, PIECHACZYK M, SABROUTY SE, DANI C, JEANTEUR P, BLANCHARD JM, 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multi-genic family. Nucl Acids Res 13: 1431-1442.
11. GATANAGA T, HWANG CD, KOHR W, CAPPUCCINI F, LUCCI J III, JEFFES EW, LENTZ R, TOMICH J, YAMAMOTO RS, GRANGER GA, 1990. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci USA 87: 8781-8784.
12. GROM AA, MURRAY KJ, LUYRINK L, EMERY H, PASSO MH, GLASS DN, BOWLIN T, EDWARD C III, 1996. Arthritis Rheum 39: 1703-1710.
13. HARRIS TJ, WALTMAN TJ, CARTER SM, MAISEL AS, 1995. Effect of prolonged catecholamine infusion on immunoregulatory function: implications in congestive heart failure. J Am Coll Cardiol 26: 102-109.
14. HELLER RA, SONG K, ONASCH MA, FISCHER WH, CHANG D, RINGOLD GM, 1990. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci USA 87: 6151-6155.
15. HIGUCHI M, AGGARWAL BB, 1992. Modulation of two forms tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodys. J Biol Chem 267: 20892-20899.
16. HIGUCHI M, AGGARWAL BB, 1994. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152: 3550-3558.
17. HOHMANN HP, REMY R, BROCKHAUS M, VAN LOON AP, 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264: 14927-14934.
18. HWANG CM, GATANAGA M, GRANGER GA, GATANAGA T, 1993a. Mechanism of release of soluble forms of tumor necrosis factor/lympotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J Immunol 151: 5631-5638.
19. HWANG S, HARRIS TJ, WILSON NW, MAISEL AS, 1993b. Immune function in patients with chronic stable congestive heart failure. Am Heart J 125: 1651-1658.
20. KAPADIA S, AMIONE-TORRE G, YOKOYAMA T, MANN DL, 1995. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 268: H517-525.
21. KATZ SD, RAO R, BERMAN JW, SCHWARZ M, DEMOPOULOS L, BIJOU R, LEJEMTEL TH, 1994. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 90: 12-16.
22. KAYAGAKI N, KAWASAKI NA, EBATA T, OHMOTO H, IKEDA S, INOUE S, YOSHINO K, OKUMURA K, YAGITA H, 1995. Metalloproteinase-mediated release of human fas ligand. J Exp Med 182: 1777-1783.
23. LEVINE B, KALMAN J, MAYER L, FILLIT HM, PACKER M, 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241.
24. LIEN E, LIABAKK NB, JOHNSON AC, NONSTAND U, SUNDAN A, ESPEVIK T, 1995. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 25: 2714-2717.
25. LIMAS CJ, GOLDENBERG IF, LIMAS C, 1995. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: correlation with disease severity and cardiac autoantibodies. Circulation 91: 631-634.
26. MAKINGS G, NAOUMOV NV, ROSSOL S, TORRE F, WONG PY, GALLATI H, PORTMANN B, WILLIAMS R, 1995. Tumor necrosis factor receptors in patients with hepatitis B virus infection. Gastroenterology 108: 1453-1463.
27. MOHLER KM, TORRANS DS, SMITH CA, 1993. Soluble TNF receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151: 1548-1561.
28. MORELAND LW, BAUMGARTNER SW, SXHIFF MH, TINDALL EA, FLEISHMANN RM, WEAVER AL, ETTLINGER RE, COHEN S, KOOPMAN RM, MOHLER K, WIDMER MB, BLOSH CM, 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337: 141-147.
29. MULLBERG J, DURIE FH, OTTEN-EVANS C, ALDERSON MR, ROSE-JOHN S, COSMAN D, BLACKRA, MOHLER KM, 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 155: 5198-5205.
30. NAKAMURA H, HINO H, KATO S, SHIBATA Y, TAKAHASHI H, TOMOIKE H, 1996. Tumor necrosis factor receptor gene expression and shedding of soluble tumor necrosis factor receptor in lung tissues and a pulmonary epithelial cell line. Eur Resir J 9: 1643-1647.
31. NOZAKI N, YAMAGUCHI S, SHIRAKABE M, NAKAMURA H, TOMOIKE H, 1997. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 61: 657-664.
32. PAGANI FD, BAKER LS, HSI C, KNOX M, FINK MP, VISNER MS, 1992. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-a in conscious dogs. J Clin Invest 90: 389-398.
33. PINCARD JK, SHEEHAN KCF, ARTHUR CD, SCHREIBER RD, 1997. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J Immunol 158: 3869-3873.
34. SEVERN A, RAPSON NT, HUNTER CA, LIEW FY, 1992. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148: 3441-3445.
35. TANENBAUM CS, MAJOR JA, HAMILTON TA, 1993. IFN-γ and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. J Immunol 151: 6833-6839.
36. TESTA M, YEH M, LEE P, FANELLI R, LOPERFIDO F, BERMAN JW, LEJEMTEL TH, 1996. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28: 964-971.
37. TORRE-AMIONE G, KAPADIA S, BENEDICT C, ORAL H, YOUNG JB, MANN DL, 1996a. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201-1206.
38. TORRE-AMIONE G, KAPADIA S, LEE J, DURAND JB, BIES RD, YOUNG JB, MANN DL, 1996b. Tumor necrosis factor-α and tumor necrosis receptors in the failing human heart. Circulation 93: 704-711.
39. VAN ZEE KJ, KOHNO T, FISHER E, ROCK CS, MOLDAWER LL, 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc Natl Acad Sci USA 89: 4845-4849.
40. VANDENABEELE P, DECLERCQ W, BEYAERT R, FIERS W, 1995. Two tumor necrosis factor: structure and function (Reviews). Trends Cell Biol 5: 392-399.
41. VILCEK J, LEE TH, 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions (Review). J Biol Chem 266: 7313-7316.
42. WILLIAMS LM, GIBBONS DL, GEARING A, MAINI RN, FELDMANN M, BRENNAN FM, 1996. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNFa processing in RA synovial membrane cell cultures. J Clin Invest 97: 2833-2841.
43. WINZEN R, WALLACH D, KEMPER O, RESCH K, HOLTMANN H, 1993. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150: 4346-4353.
44. YOKOYAMA T, VACA L, ROSSEN RD, DURANTE W, HAZSRIKA P, MANN DL, 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92: 2303-2312.
45. YOKOYAMA T, NAKANO M, BEDNARCZYK JL, MCLNTYRE BW, ENTMAN M, MANN DL, 1997. Tumor necrosis factor-a provides a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252.